gApps
  • Home
  • Directory
  • Articles
  • News
  • Resources
  • Events
  • Services
  • Advertise
  • Search
  • Menu Menu
  • Twitter
  • LinkedIn

Posts

Using Medical Apps for Diagnosing Patients

July 12, 2012/0 Comments/in Diagnosis Apps, Featured /by gApps Editorial Team

Using Medical Apps for Virtual DiagnosisIn May of this year Isabel Healthcare announced their new mobile application (app). The app is based on Isabel’s checklist system for diagnosis. The App allows doctors and nurses and other health care providers access to the app via iPhone, iPad or iPod touch mobiles.  Diagnosis can be established with the resulting possibility of treatment for patients being delivered faster.  And this innovative tool in the physician’s armoury has claimed a coveted top app rating in Apple’s Medical App category.  Where Isabel has gone many will follow and medical apps are beginning to make their presence felt in the medical community. Taking the Isabel App as an example it has been offered for download from Apple’s App Store with three subscription choices.  Customers can sign up for weekly, monthly or annual options, with the first level, the weekly option, pitched at just under £2.00 to attract the infrequent user.

Medical apps of the type offered by Isabel typically contain many thousand disease diagnostic markers both paediatric and adult and allow doctors instant access to the technologies that will help them make vital diagnoses.  Using a mobile diagnostic app a doctor does not even need to be in his hospital or clinic to diagnose a stroke in a patient and begin lifesaving treatment.  Using brain scan images that can be accessed via a smartphone and with an accuracy proven to be almost as reliable as the results of an ‘actual’ scan viewing, diagnosis can be made instantly.  This time saving ability is vital in the treatment of stroke victims.

Medical Apps – ‘Virtual’ Diagnosis?

Not everyone has welcomed this latest innovation in virtual diagnostics. There have been reservations concerning viewing detailed and complex anatomical images on a small 3.5-inch screen, from where critical emergency diagnoses will be made. However advances in image compression, microprocessors and wireless-data bandwidth, are likely to make this 21st century advance an essential diagnostic tool for doctors. For example, a CT scan image could be sent to a ‘cloud’ of the type that is commonly used as a storage device by PC users.  Downloaded to a mobile app or tablet, doctors could then zoom in to view images in more detail.  The use of this compression method to support any medical app is critical, in particular with the sending of high-resolution brain imagery.  Digital images are very large files to download and in a time sensitive situation such image files would take an hour to download using 3G or Wi-Fi.  Compression of the file overcomes this potential problem.

In countries where patients live in remote locations, this instant access diagnostic tool could prove invaluable.  In local or rural hospitals where medical staffing is limited, the instant access to patient’s results offered via this diagnostic tool, could also prove a lifesaver.

There is no doubt that this new application of technology will make a significant impact on the way in which doctors practice medicine both in and out of a hospital setting.   Gone will be the iconic picture of the consultant, clipboard in hand, with his entourage, visiting the wards.  In its place will be armies of medics with iPads and Android tablets that they can take home with them so that they always have a ‘virtual’ presence in their hospitals.

Mobile health apps need new regulatory framework

March 1, 2012/0 Comments/in News /by gApps Editorial Team

Last month, a mobile phone app became the first of its kind to be registered by the Medicines and Healthcare products Regulatory Agency (MHRA) as a medical device.

The app was developed by the team at the Mersey Regional Burns and Plastic Surgery Unit and is designed to help medical staff assess burn damages. This neat bit of kit is listed by the MHRA as a class 1 medical device and is available for free in the Apple app store.

According to research, 81% of healthcare professionals own a smartphone and as a result the Mersey Burns app will no doubt be useful by sharing the specialist knowledge from the burns unit with their medical colleagues. However, the licensing of the app has raised all kinds of questions on the future registration of mobile phone apps for use in the healthcare professions.

On the face of it, registration is eminently desirable; in healthcare accuracy is everything, so it is important that diagnostic, treatment and monitoring apps are rigorously tested to ensure their suitability for public release. Unregulated mobile health apps have the potential to put the public at risk.

However there is concern, particularly in the US, that excessive regulation of mobile apps will vastly increase the costs of app development and slow market availability down to such an extent that the technology could be out of date by the time it hits the market.

As a result, on both sides of the Atlantic, medical app developers and healthcare and pharmaceutical companies are calling for a new regulatory framework which will allow the testing and processing of relevant mobile apps at speeds equal to the pace of rapid technological change.

Drug companies increase spend on mobile and online media by nearly 80%

July 25, 2011/0 Comments/in News /by gApps Editorial Team

Pharmaceutical companies across the world increased their investments in mobile phone apps and educational websites by nearly 80% last year.

According to a study by Ernst & Young, drug companies including Merck & Co and Novartis AG are leading the way in what seems to be a new wave of enthusiasm towards social media and the online landscape on the part of drug companies.

In total, global pharmaceutical companies started 97 new projects aimed at using IT to improve the quality of patient health. By comparison, 124 project had been started in the four previous years altogether, representing a massive leap forwards for development this year.

Just over 41% of this year’s projects were apps for smartphones – an increase from 11% since 2006.

Experts say that the move is partially due to the increased pressure that pharmaceutical companies are under from governments to prove that their products are worth their prices. Plans exist in the UK to match the prices of products to their benefits starting in 2014. This therefore calls for more involvement from patients throughout the lifecycle of a drug, from initial testing to post market surveillance – all of which can be easily and effectively facilitated via the use of social media.

Carolyn Buck Luce, global pharmaceutical leader at Ernst & Young, told one US website: “Pharma can’t exist the way they have existed; what is surprising is the pace of change.”

“The next big change in health outcomes is behavioural change, where medicines play an important part but not the only part.”

Featured Articles

  • EU MDR postponed to May 2021Medical Device Regulation (MDR) is postponed until 2021July 15, 2020 - 1:23 pm
  • Avoiding app store rejection – the importance of using a medical app development specialistMay 5, 2020 - 4:48 pm
  • Tips for designing a medical deviceTips for designing a medical app – is connectivity on your list?August 2, 2016 - 11:20 am

Next Event starting in:

0Hours0Minutes0Seconds

App Developer Directory

Search or Get Listed
App developer directory

About

gApps is the UK’s leading resource for all things relating to health and medical app development.
About us

Contact us

Write for us

Directory Listing

Featured Article

  • EU MDR postponed to May 2021Medical Device Regulation (MDR) is postponed until 2021July 15, 2020 - 1:23 pm

Advertise

Learn more about advertising opportunities and getting listed in our app developers directory

Newsletter Sign-Up

© DGR Enterprises Ltd 2021 | Privacy Policy | Cookie Policy | Legal
  • Twitter
  • LinkedIn
Scroll to top

This website or its third-party tools process personal data (e.g. browsing data or IP addresses) and use cookies or other identifiers, which are necessary for its functioning and required to achieve the purposes illustrated in the cookie policy. By continuing to use this site you agree to our use of cookies.

Close

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Other cookies

The following cookies are also needed - You can choose if you want to allow them:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy Policy
Accept AllDecline AllUse Only Selected
Open Message Bar